FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Joint Panel to Mull Opioid Dependence NDA

Federal Register notice: FDA joint advisory committee meeting reviews Indivior Pharmaceuticals NDA for buprenorphine subcutaneous injection and its us...

Federal Register

Comments Sought on REMS Standards Initiative

Federal Register notice: FDA seeks public input on the design of its REMS Platform Standards Initiative, as well as methods and best practices.

Medical Devices

7 Recalled, Failed Devices Cost Medicare $1.5 Billion: IG Report

The HHS Inspector General says that seven recalled or prematurely failed cardiac devices cost Medicare $1.5 billion over nine years.

FDA General

Gottlieb Visits FDA Staff in Puerto Rico

FDA commissioner Scott Gottlieb flies to Puerto Rico 9/29 to see firsthand the devastation caused by Hurricane Maria.

Human Drugs

CDER Recognizes CDISC Clinical Data Standards Guide

Federal Register notice: CDER announces support for version 1.1 of Clinical Data Interchange Standards Consortium, Analysis Data Model Implementation ...

Federal Register

Workshop on Complex Drug Equivalence

Federal Register notice: FDA announces a 10/6 public workshop entitled Demonstrating Equivalence of Generic Complex Drug Substances and Formulations: ...

Medical Devices

FDA Reminds Device Makers of Cybersecurity Month

FDA reminds medical device makers about the beginning of National Cybersecurity Awareness Month and to remain constantly vigilant about potential vuln...

Medical Devices

FDA Guide on Requesting Feedback on Device Submissions

FDA makes available a guidance on Requests for Feedback on Medical Device Submissions: The Pre-Submission Program and Meetings with Food and Drug Admi...

Medical Devices

Draft Guide on Diagnostic Ultrasound Systems and Transducers

FDA makes available a draft guidance on Marketing Clearance of Diagnostic Ultrasound Systems and Transducers.

Human Drugs

Two FDA Guidances on Advancing Complex Drug Generics

FDA releases two guidances as part of its initiative to make it easier to introduce generic copies of complex drugs.